Prevalence of long COVID varies geographically in the United States
Feb 16, 2024
In New England and the Pacific, prevalence tended to be lower, whereas higher prevalence was seen in the South, Midwest and West.
CDC may recommend COVID boosters for some this spring
Feb 16, 2024
The panel is expected to focus on the safety of high-risk Americans, including people 65 and older and anyone with a weakened immune system.
Cognitive symptoms common with post-COVID-19 condition
Feb 15, 2024
Symptoms were linked to increased odds of at least moderate interference with functioning and lower odds of full-time employment.
COVID-19 mRNA vaccines safe during pregnancy
Feb 13, 2024
In a large study, there were lower odds of neonatal mortality associated with vaccination.
No sign latest COVID variant leads to worse symptoms
Jan 24, 2024
JN.1, the COVID variant sweeping the country this winter, is not prompting more severe disease than earlier variants did, early US government data suggest.
Vegetarian diet tied to lower COVID-19 incidence
Jan 12, 2024
No association was seen for COVID-19 severity or duration, however.
Preexisting conditions seen in all patients with tachycardia after COVID-19 vaccine
Jan 10, 2024
Reduced heart rate variability was observed in patients with postvaccination postural orthostatic tachycardia syndrome.
Nirmatrelvir during acute SARS-CoV-2 does not reduce risk for long COVID
Jan 05, 2024
No association was seen for rebound symptoms or test positivity with symptoms of long COVID.
Nearly half of US COVID-19 cases now caused by JN.1 variant
Dec 28, 2023
The speed at which the JN.1 variant has spread this month suggests that it may spread more easily and be better at evading the immune system.
Fourth COVID-19 shot beneficial in patients with autoimmune rheumatic diseases
Nov 28, 2023
A fourth dose reduces the risk for SARS-CoV-2 for patients with systemic autoimmune rheumatic diseases using DMARDs.